Delhi Journal of Ophthalmology

Expanded Indications of Plaque Brachytherapy

Rashmi Singh, Neiwete Lomi, Bhavna Chawla
Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India

Editor-in-Chief, Delhi Journal of Ophthalmology, Dr R.P.Centre, AIIMS.


Corresponding Author:

Rashmi Singh MD
Dr. Rajendra Prasad Centre for OphthalmicSciences,
All India Institute of MedicalSciences,
New Delhi, India
Email id: rasshmi1301@gmail.com


Published Online: 08-MAY-2019
DOI: https://dx.doi.org/10.7869/djo.436

AbstractRadiotherapy is now a widely accepted treatment modality in oncology. Plaque brachytherapy is an effective eye and vision sparing alternative to enucleation for patients with intraocular tumours. The most common indication for brachytherapy is malignant tumours like retinoblastoma and uveal melanoma. Over the years, brachytherapy is being increasingly used for other conditions affecting the eye and ocular adnexa. These include ocular surface tumours and some benign lesions where traditional methods of treatment have failed such as retinal capillary hemangiomas, vasoproliferative tumours, choroidal hemangiomas and choroidal neovascularization in age-related macular degeneration. The expanded applications of plaque therapy are summarized in this review.
Keywords :Plaque bracytherapy, Indications, Tumours, Benign